Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Jeremy Bordeaux, MD

Jeremy Bordeaux, MD

  • Director, Mohs Micrographic and Dermatologic Surgery, UH Cleveland Medical Center
  • Director, Melanoma Program, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Specialty: Dermatology, Dermatology-MOHS Micrographic Surgery
  • Location:
    University Hospitals
    3000 Auburn Dr
    Beachwood, OH 44122

Biography: Jeremy Bordeaux, MD


  • Dermatologic Surgery
  • Dermatology
  • High risk basal cell and squamous cell carcinomas
  • Melanoma
  • Mohs Micrographic Surgery
  • Reconstructive Surgery of Skin Cancer Wounds
  • Surgical Management of Skin Cancers

Certifications & Memberships

  • Micrographic Dermatologic Surgery - American Board of Dermatology
  • Dermatology - American Board of Dermatology


Fellowship | MOHS-Micrographic Surgery
MOHS-Micrographic Surgery - University Of Massachusetts Memorial Medical Center - University Campus (2006 - 2007)

Residency | Dermatology
Dermatology - University Of Massachusetts Memorial Medical Center - University Campus (2003 - 2006)

Internship | Internal Medicine
Internal Medicine - The Jewish Hospital - Mercy Health (2002 - 2003)

Other Education
University Of North Carolina At Chapel Hill (2000 - 2002)

Medical Education
Duke University School Of Medicine (1998 - 2002)

North Carolina State University (1994 - 1998)

Research & Publications

Research Links

View Research

Research Interests

Skin cancer research, Cancer epidemiology research, Health disparities, Outcomes research

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Jeremy Bordeaux did not disclose any Outside Relationships with Industry.